PetIQ Inc. (PETQ) |
|
33.03 1.12 (3.51%)
|
09-29 00:34 |
|
Open: |
32.24 |
Pre. Close: |
31.91 |
|
High:
|
33.19 |
Low:
|
32.24 |
|
Volume:
|
333,101 |
Market Cap:
|
944M |
|
|
|
|
PetIQ, Inc. is a holding company, which engages in the manufacture, procurement, packaging, and distribution of pet health and wellness products. The company is headquartered in Eagle, Idaho and currently employs 1,452 full-time employees. The firm provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield. The company distributes the products through veterinarian, retail and e-commerce channels. The firm offers its products in a range of categories, including Rx Medications, OTC Medications and Supplies, and Health and Wellness Products. Rx Medications offering includes heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics and other specialty medications. The firm manufactures Heart Shield Plus, version of Heartgard Plus, which prevents heartworm infection in dogs. The firm also manufactures TruProfen, the version of Rimadyl, which treats arthritis in dogs. OTC Medications and Supplies include flea and tick control products. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
33.193 - 33.309 |
33.309 - 33.415 |
|
Low:
|
31.908 - 32.057 |
32.057 - 32.193 |
|
Close:
|
32.792 - 33.001 |
33.001 - 33.193 |
|
Technical analysis |
as of: 2020-09-28 4:36:11 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, downgraded from strong buy. Upward movement continues, but could change at any time. |
| Target: |
Six months: 41.74  One year: 48.76 |
| Support: |
Support1: 31.44 Support2: 28.79 |
| Resistance: |
Resistance1: 35.74 Resistance2: 41.74 |
| Pivot: |
31.18 |
| Moving Average: |
MA(5): 30.94 MA(20): 31.96
MA(100): 32.13 MA(250): 28.47 |
| MACD: |
MACD(12,26): -0.43 Signal(9): -0.56 |
| Stochastic oscillator: |
%K(14,3): 64.59 %D(3): 39.84 |
| RSI: |
RSI(14): 56.39 |
| 52-week: |
High: 38.99 Low: 15.83 Change(%): 25.5 |
| Average Vol(K): |
3-Month: 40685 10-Days: 25553 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.PETQ has closed below upper band by 2.1%. Bollinger Bands are 37.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Mon, 28 Sep 2020
PetIQ Inc (NASDAQ:PETQ) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Wed, 09 Sep 2020
PetIQ (NASDAQ:PETQ) Cut to "Hold" at BidaskClub - MarketBeat
Tue, 08 Sep 2020
PetIQ, Inc. (PETQ) Provides Update on Wellness Center Reopening Plan - StreetInsider.com
Wed, 02 Sep 2020
Petiq (PETQ) Receives a New Rating from a Top Analyst - Analyst Ratings
Mon, 31 Aug 2020
Zacks: Analysts Anticipate PetIQ Inc (NASDAQ:PETQ) Will Announce Quarterly Sales of $169.75 Million - MarketBeat
Thu, 06 Aug 2020
PetIQ, Inc. Reports Record Second Quarter 2020 Financial Results - GlobeNewswire
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Underperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Drug Manufacturers General Specialty & Generic |
| Shares Out. (M) |
25 |
| Shares Float (M) |
21 |
|
% Held by Insiders
|
0.95 |
|
% Held by Institutions
|
116.21 |
|
Shares Short (K)
|
5,460 |
|
Shares Short P. Month (K)
|
4,960 |
Stock Financials |
|
EPS
|
-0.890 |
|
EPS Est This Year
|
0.740 |
|
EPS Est Next Year
|
0.860 |
|
Book Value (p.s.)
|
13.080 |
|
Profit Margin
|
-2.63 |
|
Operating Margin
|
2.21 |
|
Return on Assets (ttm)
|
1.6 |
|
Return on Equity (ttm)
|
-7.7 |
|
Qtrly Rev. Growth
|
21.0 |
|
Gross Profit (p.s.)
|
4.762 |
|
Sales Per Share
|
31.867 |
|
EBITDA (p.s.)
|
1.497 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-4 |
|
Levered Free Cash Flow (M)
|
-23 |
Stock Valuations |
|
PE Ratio
|
-37.11 |
|
PEG Ratio
|
1.14 |
|
Price to Book value
|
2.53 |
|
Price to Sales
|
1.04 |
|
Price to Cash Flow
|
-228.01 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
